PetMed Express, Inc. (PETS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 284 | 304 | 273 | 257 | 274 | 227 | 179 | 169 |
| Operating profit | $m | -31 | -31 | ||||||
| Net profit | $m | 26 | 24 | 21 | 5 | -7 | -6 | -57 | -29 |
| EPS reported | $ | -2.74 | -1.38 | ||||||
| Operating cashflow per share | $ | -1.36 | -1.10 | ||||||
| Capex per share | $ | 0.22 | 0.18 | ||||||
| FCF per share | $ | -1.58 | -1.28 | ||||||
| Free cash flow | $m | -33 | -28 | ||||||
| Net debt | $m | -21 | -13 | ||||||
| Book value equity | $m | 29 | 23 | ||||||
| Book value per share | $ | 1.38 | 1.06 | ||||||
| Number of shares | m | 20.92 | 21.68 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.65 | 3.75 | ||||||
| P/S LTM | x | 0.22 | 0.51 | ||||||
| P/FCF LTM | x | -1.45 | -3.11 | ||||||
| EV/EBITDA LTM | x | -11.16 | -1.50 | ||||||
| EV/Sales LTM | x | 0.18 | 0.16 | ||||||
| Earnings Yield LTM | % | -39.00% | -73.99% | ||||||
| FCF Yield | % | -69.20% | -32.18% | ||||||
| Quality | |||||||||
| ROE | % | -197.95% | -91.67% | ||||||
| ROIC | % | -1.06% | -1.30% | ||||||
| Operating margin | % | -17.55% | -18.22% | ||||||
| Gross margin | % | +22.81% | +23.71% | ||||||
| FCF/Sales | % | -18.44% | -16.45% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -21.13% | -38.40% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.04% | 0.00% | ||||||
| Dividend Growth | % | -88.58% | -99.85% | ||||||
| Payout Ratio | % | -0.04% | -0.09% | ||||||
| FCF/Debt | x | -61.70 | -67.09 | ||||||
| Net Debt/EBITDA | x | 0.95 | 0.58 | ||||||
| EBIT/Net interest | x | 0.00 | -69.47 | ||||||
| Net debt/market cap | % | +1.03% | +1.06% | ||||||
| Net debt/Equity | x | -0.72 | -0.55 | ||||||
| Gross debt/equity | x | 0.02 | 0.02 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
PetMed Express, Inc. (PETS)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free